These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 30675881

  • 1. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
    Chen K, Chen X, Xue H, Zhang P, Fang W, Chen X, Ling W.
    Food Funct; 2019 Feb 20; 10(2):814-823. PubMed ID: 30675881
    [Abstract] [Full Text] [Related]

  • 2. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
    Inamdar S, Joshi A, Malik S, Boppana R, Ghaskadbi S.
    Biochem Biophys Res Commun; 2019 Oct 29; 519(1):106-112. PubMed ID: 31472955
    [Abstract] [Full Text] [Related]

  • 3. Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice.
    Park M, Yoo JH, Lee YS, Lee HJ.
    Nutrients; 2019 Feb 26; 11(3):. PubMed ID: 30813654
    [Abstract] [Full Text] [Related]

  • 4. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y, Choi SI, Hong E, Kim GH.
    J Food Sci; 2020 Jul 26; 85(7):2216-2226. PubMed ID: 32579753
    [Abstract] [Full Text] [Related]

  • 5. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 6. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.
    Eur J Pharmacol; 2016 Oct 05; 788():200-209. PubMed ID: 27343380
    [Abstract] [Full Text] [Related]

  • 7. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 05; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 8. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS, Park CM, Kim HA, Kim HJ, Park JW, Park JC, Rhyu DY.
    J Ethnopharmacol; 2024 Feb 10; 320():117395. PubMed ID: 37952731
    [Abstract] [Full Text] [Related]

  • 9. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, Xia M, Chang X, Lu Y, Li Y, Xia P, Li X, Gao X.
    Free Radic Biol Med; 2019 Sep 10; 141():192-204. PubMed ID: 31226399
    [Abstract] [Full Text] [Related]

  • 10. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

  • 11. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW.
    Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073834
    [Abstract] [Full Text] [Related]

  • 12. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
    Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, Huang WC.
    Cells; 2019 May 11; 8(5):. PubMed ID: 31083505
    [Abstract] [Full Text] [Related]

  • 13. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020 May 11; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 14. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
    Xiao Z, Chu Y, Qin W.
    Life Sci; 2020 Sep 01; 256():117997. PubMed ID: 32585242
    [Abstract] [Full Text] [Related]

  • 15. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
    Liu H, Zhong H, Yin Y, Jiang Z.
    Biomed Pharmacother; 2017 Jul 01; 91():964-969. PubMed ID: 28514835
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, Zhang J, Wang T, Xin W, Yu C, Guan Q, Zhou X, Gao L, Xu C, Zhao J.
    J Hepatol; 2014 Dec 01; 61(6):1358-64. PubMed ID: 25016220
    [Abstract] [Full Text] [Related]

  • 17. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M, Gavito AL, Pavón FJ, Bautista D, Serrano A, Suarez J, Arrabal S, Decara J, Romero-Cuevas M, Rodríguez de Fonseca F, Baixeras E.
    Dis Model Mech; 2015 Jul 01; 8(7):721-31. PubMed ID: 26035386
    [Abstract] [Full Text] [Related]

  • 18. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS, Kim JH, Kim HJ, Chang KC, Park SW.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):113-24. PubMed ID: 25737164
    [Abstract] [Full Text] [Related]

  • 19. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA, Hwang YJ, Kim GR, Choe JS.
    BMC Complement Altern Med; 2015 Oct 05; 15():347. PubMed ID: 26438035
    [Abstract] [Full Text] [Related]

  • 20. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC.
    Cell Physiol Biochem; 2018 Oct 05; 49(5):1870-1884. PubMed ID: 30235452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.